Cabozantinib (C) versus placebo (P) in patients (pts) with advanced hepatocellular carcinoma (HCC) who have received prior sorafenib: results from the randomized phase 3 CELESTIAL trial
ONCOLOGY RESEARCH AND TREATMENT, cilt.41, ss.254, 2018 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Özet
- Cilt numarası: 41
- Basım Tarihi: 2018
- Dergi Adı: ONCOLOGY RESEARCH AND TREATMENT
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Sayfa Sayıları: ss.254
- Trakya Üniversitesi Adresli: Evet